Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies

por Hwang, Thomas J.
Publicado 2013

Periorbital Injectables: Understanding and Avoiding Complications

por Hwang, Catherine J
Publicado 2016

Serial specification of diverse neuroblast identities from a neurogenic placode by Notch and Egfr signaling

por Hwang, Helen J., Rulifson, Eric
Publicado 2011

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment

por Hwang, Thomas J., Keshavjee, Salmaan
Publicado 2014

Biomarkers of Cervical Dysplasia and Carcinoma

por Hwang, Sonya J., Shroyer, Kenneth R.
Publicado 2012

Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016

por Hwang, Thomas J, Kesselheim, Aaron S, Gyawali, Bishal
Publicado 2018

Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002–2012

por Hwang, Jenny, Hwang, Thomas J, Ciolino, Joseph B
Publicado 2015

Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study

por Hwang, Thomas J., Tomasi, Paolo A., Bourgeois, Florence T.
Publicado 2018

Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart

por Hwang, C J, Fields, J R, Shiao, Y-H
Publicado 2011

The role of Ca(2+) and protein scaffolding in the formation of nature’s water oxidizing complex

por Avramov, Anton P., Hwang, Hong J., Burnap, Robert L.
Publicado 2020

Therapeutic results and prognostic predictors of childhood acute lymphoblastic leukemia: Cox regression analysis.

por Kook, H., Hwang, T. J., Yang, D. W., Moon, J. D.
Publicado 1991

Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study

por Hwang, Thomas J, Sokolov, Elisaveta, Franklin, Jessica M, Kesselheim, Aaron S
Publicado 2016

Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study

por Hwang, Thomas J, Ross, Joseph S, Vokinger, Kerstin N, Kesselheim, Aaron S
Publicado 2020

Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021

por Patel, Neeraj G., Hwang, Thomas J., Woloshin, Steven, Kesselheim, Aaron S.
Publicado 2023

Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012

por Hwang, Thomas J., Lauffenburger, Julie C., Franklin, Jessica M., Kesselheim, Aaron S.
Publicado 2016

Successful allogeneic bone marrow transplantation for childhood-onset refractory anemia with ringed sideroblasts.

por Kook, H., Kim, C. J., Yoon, W. S., Ryang, D. W., Hwang, T. J.
Publicado 2000

Tobacco etch virus (TEV) protease with multiple mutations to improve solubility and reduce self‐cleavage exhibits enhanced enzymatic activity

por Nam, Heejin, Hwang, Beom J., Choi, Deog‐Young, Shin, Sooim, Choi, Moonsung
Publicado 2020

Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019

por Vokinger, Kerstin N., Hwang, Thomas J., Glaus, Camille E. G., Kesselheim, Aaron S.
Publicado 2022

Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021

por Vokinger, Kerstin N., Kesselheim, Aaron S., Glaus, Camille E. G., Hwang, Thomas J.
Publicado 2022

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021

por Pathak, Kavya, Narang, Claire, Hwang, Thomas J., Espinoza, Juan C., Bourgeois, Florence T.
Publicado 2022